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Introduction 
During the last few years our know-
ledge of auto immune disease has increased 
considerably, and the techniques for de-
tecting such disease have been improved 
and made simpler. The laboratory tests 
to detect humoral antibodies in patients 
suffering from an auto immune disorder 
have become routine in a number of 
hospitals and the use of techniques, and, 
in particular immunofluorescence techni-
ques, have assumed greater importance. 
The purpose of the present communi-
cation is to outline some of the available 
immunopathological techniques and to 
illustrate how they are applied in the day 
to day investigation of patients in an 
acute general hospital. 
Immunopathological Techniques 
A) Immunofluorescent methptls 
The indirect immunofluorescence tech-
nique - also called the "sandwich" 
method - is used in most cases (Nairn 
1969). Normal tissue is snap-frozen in a 
liquid nitrogen-isopentane mixture (tem-
perature -IS0°C) and stored for future 
use at -70°C. When required, frozen sec-
tions are cut and the patient's serum 
layered on top of the section. (Fig. 1). 
Antibodies present in the serum will com-
bine with antigenic sites in the tissue sec-
tion. Excess serum is then washed off, and 
a fluorescene-conjugated rabbit anti-
human globulin is applied to the section 
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- this last layer will attach to any globu-
lin remaining on the section, thereby lo-
calising any antigen-antibody reaction. 
Fig. 1 
Using this method a number of tests 
have been devised to detect antibodies in 
human sera. Antinuclear antibodies (Fig. 2) 
are best detected using rat liver sections. 
Fig. 2 
Such antibodies are present in about 100% 
of patients suffering from lupus erythe-
matosus. Antibodies to gastric parietal 
cells can likewise be demonstrated in the 
sera of 90% of patients suffering from per-
nicious anaemia. (McKay, 1969) (Fig. 3). 
In auto immune disorders affecting the 
thyroid gland, two distinct antibodies may 
be detected by immunofluorescence. First-
Fig. 3 
ly a cytoplasmic antibody reacting with 
the cytoplasm of cells lining the vesicles 
(Fig. 4), and secondly, an antibody react-
ing with thyroglobulin (Fig. 5). Antithy-
roglobulin antibodies are present in 90% 
of patients with Hashimoto's disease and 
Fig. 4 
Fig. 5 
anticytoplasmic antibodies are present in 
about 70% of patients with thyrotoxicosis. 
Other immunofluorescence tests that 
yield useful information are: 
Fig. 6 
a) Antimitochondrial antibodies (Fig. 
6). These antibodies, best detected in kid-
ney tubule cells are present in about 
79-94% of patients with primary biliary 
cirrhosis, and since such antibodies are 
not present in patients with extrahepatic 
jaundice, their presence is· useful in the 
differential diagnosis of these two condi-
tion. (Brit. Med. J. 1970, Doniach 1968. 
Fig. 7 
b) Anti smooth muscle antibodies 
(Fig. 7). These are present in cases of 
lupoid hepatitis. 
Fig. 8 
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c) Anti striated muscle antibodies 
(Fig. 8) are present in cases of myasthenia 
gravis, about 30% of which show the 
typical band fluorescence. 
d) Anti adrenal cortex antibodies 
are present in about 50% of patients with 
Addison's disease. 
Fig. 9 
e) In skin disorders, antibodies 
against the intercellular area and cell 
membranes of squamous epithelium are 
present in pemphigus VUlgaris (Fig. 9), 
while anti-basement membrane zone anti-
bodies are present in Bullous pemphigoid 
(Fig. 10). So characteristic are these 
changes that the presence of such anti-
bodies is virtually diagnostic. (Muller and 
Sutherland, 1970). 
Fig. 10 
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Fig. 11 
f) In ulcerative colitis, anticolon mu-
cus antibodies can be detected (Fig. 11 . 
(McGiven et aI., 1967). 
g) Using specific antisera to immu-
noglobin IgG,' IgM, IgA as well as anti-
fibrin, anti complement etc., direct visua-
lisation of the exact nature of antigen 
antibody complex can be achieved. (This 
is an example of the direct immunofluo-
rescent technique, as opposed to the above 
test where the indirect test is used). 
B) Tanned Red Cell Haemagglutination 
Technique 
Tanned sheep red cells have the 
power of combining with a number of an.ti-
gens (Herbert, 1967). Thyroglobulin is such 
an antigen that can be readily attached to 
sheep red cells to produce a very useful 
reagent for the detection of antithyroglo-
bulin antibodies. Briefly, thyroglobulin-
coated cells (supplied by "Wellcome") are 
added to a series of tubes containing se-
Fig. 12 
rial dilutions of the patient's serum. Agglu-
tination of the red cells occurs in those 
tubes containing sufficient antibody. In 
Hashimoto's disease, this test is positive 
in 90% of cases (McKay, 1969). 
C) Latex Agglutination 
In rheumatoid arthritis, the latex ag-
glutination test is used to detect rheuma-
toid factor. Latex particles coated with 
human y globulin are supplied in kit form 
(Hyland). When one drop of test serum 
-(diluted 1/20) is added to 1 drop of lat8x-
globulin reagent, macroscopic clumping 
occurs. 
Other Tests Not Used Routinely 
A) Mixed Antiglobulin Test (Coombs 
and Gell, 1968) 
This is a very sensitive test for de-
tecting very small amounts of circulating 
antibodies to cellular constituents, such as 
peripheral blood lymphocytes, tumour 
cells, etc. In principle, (Fig. 12), lympho-
cytes or other cells to be tested are wash-
ed free of serum and the test serum is then 
added. After a suitable interval, the cells 
are washed again and antihuman serum 
(e.g. rabbit antihuman globulin) is added 
so that the cells are coated with a layer 
of human serum, and then with a second 
layer of rabbit anti-human globulin (Fig. 
12A). As an indicator system, sheep red 
cells coated with human globulin are used 
(Fig. 12B). When mixed together, typical 
Fig. 13 
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rosettes are formed consisting of a central 
lymphocyte surrounded by sheep red cells 
(Fig. 12C, Fig. 13). This technique can be 
used to demons,trate specific antibodies 
to cell membranes such as antibodies to 
tumour cells (Mori and Coombs, 1969). 
B) Membrane Immunofluorescence 
In routine immunofluorescence tests, 
the tissue is frozen - a process which 
kills cells - and then serum is layered 
on, so that it comes in contact with the 
intracellular constituents, e.g. cytoplasm, 
nuclei etc. The technique of membrane 
immunofluorescence enables the detection 
of antigens present on the membrane of 
cells, and in this context it is well to re-
member that the cell membrane may well 
be a very important antigenic constituent 
in a number of immunological situations. 
Theoretically, the technique of mem-
brane immunofluorescence is quite sim-
ple. The cell suspension to be tested (e.g. 
tumour cells) is first washed, and then the 
test serum is added. After half an hour, the 
cells are again washed and fluorescene-
conjugated antihuman globulin added. A 
drop of cells is then examined by fluo-
rescent microscopy. When the reaction is 
positive, the cell surface shows a ring of 
bright fluorescence. 
The main value of this technique is to 
localise antigens situated on the cell sur-
face, such as tumour specific transplanta-
tion antigens, HL-A antigens, etc. 
The Routine Investigation of Patients 
Suffering from Autoimmune Disease 
The rest of this communication will 
deal with the results obtained from tests 
performed on 1000 consecutive patients 
suffering from a number of unrelated dis-
orders. It is to be emphasised that these 
results do not in any way represent a sur-
vey of the incidence of the various dis-
eases. Rather it is hoped that these results 
will illustrate a number of facets common 
to auto immune disease in general. 
As seen in Table 1, out of 1000 pa-
tients tested, 481 had one or more posi-
tive tests. The very high incidence illus-
trates the selection of cases referred for 
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LEGENDS TO FIGURES: 
Fig. 1. Diagrammatic representation of the indirect immunofluorescence 
test. (See text). 
Fig. 2. Anti nuclear antibodies. Liver sections treated with anti ANF 
sera show bright staining of cell nuclei. 
Fig. 3. Anti gastric parietal cell antibodies. Sections of stomach fundus 
to show positive parietal cell staining. 
Fig. 4. Anti thyroid cytoplastic antibodies to show staining of cytoplasm 
in human thyroid. 
Fig. 5. Anti thyroglobulin. Typical flocculent staining of colloid inside 
thyroid vesicles. 
Fig. 6. Anti mithochondrial antibodies. Kidney sections showing cells 
lining the tubules staining positively. The glomeruli are negative. 
Fig. 7. Anti smooth muscle antibodies. 
Fig. 8. Anti striated muscle antibodies. 
Fig. 9. Anti bodies to intercellular area from a case of pemphigus vul-
garis (courtesy of Dr. H. K. Muller). 
Fig. 10. Anti basement membrane zone staining in Bullous pemphigoid 
(courtesy of Dr. H. K. Muller). 
Fig. 11. Anti colon mucus antibodies in ulcerative colitis. 
Fig. 12. Principle of the mixed antiglobulin test: 
A: Test cell coated with test serum and anti human serum. 
B: Indicator Sheep Red Blood Cells coated with human globulin. 
C: Mixing of test cells with indicator cells resulting in mixed 
agglutination. 
Fig. 13. Rosette formation in the Mixed Antiglobulin Test, showing 
lymphocytes surrounded by red cells. 
TABLE 1 
Incidence and sex ratio of patients 
having one or more positive 
immunological tests 
M : F Ratio 
Number of patients 
tested 1000 1 1.5 
Number of patients with 
positive tests 481 1 1.9 
immunological studies. It is to be noted 
that the sex ratio of patients having a 
positive immunological test is heavily 
loaded towards females in the ratio of 
1 : 1.9 (compared to 1 : 1.5 for the patients 
in general). 
TABLE 2 
Incidence of individual positive results 
Test Number positive 
Anti nuclear factor (ANF) 82 
Anti gastric parietal cell (AGPC) 260 
Anti thyroid cytoplasm (Cyto) 130 
Anti thyroid colloid (ColI) 32 
Anti mitochondrial (Mito) 13 
Anti smooth muscle (S M) 30 
Rheumatoid Factor (R.A.) 92 
Tanned Red cell 
Agglutination (TRC) 78 
Table 2 shows the incidence of the 
individual positive tests. Antigastric pa-
rietal cell antibodies were the commonest 
ones encountered (26%). Antithyroid tests 
(including anti-cytoplasmic, colloid, and 
tanned red ceU tests) were positive in 
3.2-13.0%1 of the patients, depending on 
the test used. Antinuclear factor was evi-
dent in 8.2% of patients. 
TABLE 3 
Patients having "single" or "multi" 
system involvement * 
Number of patients having 
one positive test 298 
Number of patients having 
two positive tests 136 
Number of patients having 
three positive tests 47 
(,' Anti thyrQ'd cytoplasmic and anti thyroid colloid 
antibody and tanned red cell agglutinaiton represent one 
single system involvement, and hence were counted as one 
test for the purpose of this table.) 
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In many cases there was more than 
one antibody present in the serum. 
Table 3 shows that 136 patients had two 
positive tests. (For this purpose, the three 
different antithyroid tests, viz, anti cyto-
plasmic, anti colloid and tanned red cell 
agglutination, were considered as one 
test). 47 patients had antibodies reacting 
with three different systems, e.g. antigas-
tric, anti thyroid as well as anti nuclear. 
This relationship is further analysed in 
Table 4 which illustrates the frequency 
of association of antibodies in autoim-
mune disorders. For example anti parietal 
cell antibody is found associated with anti 
thyroid cytoplasmic antibody in 51 pa-
tients, and with RA test in 33 patients. 
Similarly, antithyroid cytoplasmic anti-
body is found in 15 patients having anti 
nuclear factor, in 24 patients having anti 
colloid, in 51 patients having a positive 
TRC, as well as in 15 patients having a 
positive RA. 
TABLE 4 
The frequenecy of association 
of positive tests 
11 ANF 1 AGPC 1 CYTO I Call. I Milo I s.m.' RA 1 TRC I 
I ANF I - 17 15 I 2 I-I 2 1191 121 
AGPC 17 - 51 13 9 7 331 34 
Cyto 15 51 - 24 4 3 151 51 
ColI 2 13 24 - 1 1 5 23
1 
RA 19 33 15 5 3 1 - 10
1 
TRC 12 34 51 23 2 4 10 
-J 
To be noted also the high incidence 
of anti gastric parietal cell positive sera 
in RA positive patients. RA tests were not 
done routinely on all patients, but there 
was no reason to suspect that AGPC po-
sitive patients were selected for RA tests. 
Tanned red cell tests were done only on 
those patients with a positive anti cyto-
plasmic or anti colloid antibody. This ex-
plains the positive correlation of immuno-
fluorescent tests for thyroid disease and 
a positive TRC: Out of 78 patients with 
positive TRC test, 51 were associated 
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with a positive anti thyroid cytoplasmic 
antibody, and 23 with anti thyroid colloid 
antibody. The association of positive TRC 
and anti AGPC however represents the 
association of auto immune disease affect-
ing both thyroid and gastric cells. 
Although the data presented above 
are selected and not meant to indicate 
the true incidence of auto immune disease, 
nevertheless several important conclusions 
can be drawn from this study: 
1) The importance of performing 
immunological tests on patients in a gene-
ral hospital population. 
2) The greater incidence of auto-
immune disease in females. 
3) The importance of testing all pa-
tients with a battery of tests and not just 
with a single test. In many instances it 
can be shown that the patient serum was 
negative for a suspected lesion, e.g. ANF, 
but positive for AGPC or antithyroid anti-
bodies. 
4) It has further been shown that in 
certain instances which are not uncom-
mon, a "multisystem" autoimmune disor-
der is present associated with a whole host 
of abnormal antibodies. 
5) Finally, in drawing any conclu-
sions from immunological tests of this na-
ture it is important to keep in mind the 
tendency for antibodies to appear with 
advancing age (Whittingham et al., 1969). 
Apart from the fascinating correlation 
between the process of ageing and auto-
immune disease which this observation 
entails, i,t is essential to keep in mind the 
fact that the presence of antibody is not 
tlecessarily causing the disease, but may 
be a secondary accompaniment of tissue 
breakdown and destruction. It has been 
shown, for example, that destruction of 
peripheral blood cells by irradiation is fol-
lowed by antileucocyte antibodies in the 
serum (Suzuki, 1969), and that the level 
of antibodies to Burkitt Lymphoma cells 
is greater after chemotherapy, which pre-
sumably involves massive destruction of 
tissue and cells (Yata et al., 1970). It is 
conceivable that some similar or related 
process is occurring in the aged popula-
tion. 
In all cases, however, a careful as-
sessment of the immunological status of 
patients suffering from a variety of (usual-
ly chronic) disorders, using both humoral 
antibody techniques described above, as 
well as techniques that measure the cel-
lular immunological potential, are essen-
tial in the proper evaluation of the immu-
nological status of patients. 
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